Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 132, pseudogene (RN7SL132P) is a nonfunctional genomic sequence similar to the functional 7SL RNA gene, but lacking coding potential and unable to produce a functional RNA product[4][1][3]. Pseudogenes like RN7SL132P are typically truncated or mutated, resulting from the integration of reverse-transcribed RNA sequences into the genome or duplication and subsequent loss of function. While the parent 7SL RNA plays an essential architectural and regulatory role in the signal recognition particle (SRP)—which mediates protein targeting to the endoplasmic reticulum and is involved in cellular protein trafficking—pseudogenes such as RN7SL132P are transcriptionally silent or produce nonfunctional transcripts, with no demonstrated involvement in cellular signaling, disease processes, or response to therapeutics[4][3][1][6][5]. Their main relevance is as genetic fossils, and they do not function as receptors, enzymes, drug targets, or biomarkers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 132, pseudogene (RN7SL132P).